home / stock / gth / gth news

GTH News and Press, Genetron Holdings Limited From 09/25/20

Stock Information
Company Name: Genetron Holdings Limited
Stock Symbol: GTH
Market: NASDAQ
Website: genetronhealth.com
Menu
GTH GTH Quote GTH Short GTH News GTH Articles GTH Message Board
Get GTH Alerts

News, Short Squeeze, Breakout and More Instantly...
GTH - Genetron Health/CStone initiates trial for under-development companion diagnostic test for avapritinib

Genetron (GTH) and its partner CStone Pharmaceuticals (CSPHF) have launched a clinical trial in China for the development of a companion diagnostic test for avapritinib, a kinase inhibitor discovered by CStone’s partner Blueprint Medicines.The test kit will detect the D8...
GTH - Genetron Health and CStone Pharmaceuticals Announce Launch of Clinical Trial in China for Companion Diagnostic Test in Development for Avapritinib

BEIJING and SUZHOU, China, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and com...

GTH - Genetron Health to Highlight Data from 18 Studies at ESMO 2020

Genetron Health to present data at ESMO 2020 relating to precision oncology diagnostic development initiatives across lung, gastrointestinal and other cancer types, and to bioinformatics development BEIJING, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron...

GTH - Genetron Health and dMed Announce Partnership Agreement

BEIJING, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, and dMed Biopharmaceutical (“dMe...
GTH - Genetron Health to Present at Upcoming Investor Conferences

BEIJING, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, today announced that its execut...

GTH - Genetron Health Joins Major R&D Project Led by the Ministry of Science and Technology in China for Early Screening of Lung and Digestive System Cancers

BEIJING, Aug. 29, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, today announced its partici...

GTH - Genetron Holdings EPS beats by $0.06, beats on revenue

Genetron Holdings (NASDAQ: GTH ) : Q2 Non-GAAP EPS of -$0.04 beats by $0.06 ; GAAP EPS of -$2.41 misses by $2.32 . Revenue of $14.4M beats by $1.21M . Press Release More news on: Genetron Holdings Limited, Earnings news and commentary, Healthcare stocks news,

GTH - Genetron Health Reports Second Quarter 2020 Unaudited Financial Results

BEIJING, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, today announced its unaudited financial ...

Previous 10 Next 10